Daniel G. Baker

Insider Reports History

Location
Boston, MA
Signature
/s/ Daniel G. Baker by Colin Sandercock, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel G. Baker:

Form 4 holding CHIEF DEVELOPMENT OFFICER

Cue Biopharma, Inc.

Security class
Stock Option (right to buy)
Shares / value
100,000
Estimated value
Report date
09 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Shattuck Labs, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
66,300
Estimated value
Report date
28 Aug 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Daniel G. Baker

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .